Gutwerg Ori 4
4 · ANI PHARMACEUTICALS INC · Filed Feb 18, 2025
Insider Transaction Report
Form 4
Gutwerg Ori
SVP, GENERICS
Transactions
- Award
Common Stock
2025-02-12+10,444→ 103,339 total - Tax Payment
Common Stock
2025-02-14$58.92/sh−1,426$84,020→ 101,913 total - Award
Common Stock
2025-02-12+15,668→ 92,895 total - Tax Payment
Common Stock
2025-02-15$58.92/sh−1,167$68,760→ 100,746 total
Footnotes (4)
- [F1]Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025.
- [F2]These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting.
- [F3]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,690 shares of restricted stock, the grant of which was previously reported.
- [F4]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,227 shares of restricted stock, the grant of which was previously reported.